EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer

By Tomasini Pascale   Serdjebi Cindy   Khobta Nataliya   Metellus Philippe   Ouafik L’Houcine   Nanni Isabelle   Greillier Laurent   Loundou Anderson   Fina Frederic   Mascaux Celine   Barlesi Fabrice  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2132-2132

MDPI

Access to resources Recommend Favorite

Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK

By Rothschild Sacha I.  

Cancers, Vol. 7, Iss. 2, 2015-05 ,pp. : 930-949

MDPI

Access to resources Recommend Favorite

EGFR Mutations in Surgically Resected Fresh Specimens from 697 Consecutive Chinese Patients with Non-Small Cell Lung Cancer and Their Relationships with Clinical Features

By Lai Yuanyang   Zhang Zhipei   Li Jianzhong   Sun Dong   Zhou Yong’an   Jiang Tao   Han Yong   Huang Lijun   Zhu Yifang   Li Xiaofei   Yan Xiaolong  

International Journal of Molecular Sciences, Vol. 14, Iss. 12, 2013-12 ,pp. : 24549-24559

MDPI

Access to resources Recommend Favorite

Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer

By Lococo Filippo   Paci Massimiliano   Rapicetta Cristian   Rossi Teresa   Sancisi Valentina   Braglia Luca   Cavuto Silvio   Bisagni Alessandra   Bongarzone Italia   Noonan Douglas M.   Albini Adriana   Maramotti Sally  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. : 19612-19630

MDPI

Access to resources Recommend Favorite

­­Depletion of Amyloid Precursor Protein (APP) Causes G0 Arrest in Non‐Small Cell Lung Cancer (NSCLC) Cells

By  

JOURNAL OF CELLULAR PHYSIOLOGY, Vol. 230, Iss. 6, 2015-06 ,pp. : 1332-1341

John Wiley & Sons Inc

Access to resources Recommend Favorite